Erica Quaquarini
Overview
Explore the profile of Erica Quaquarini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quaquarini E, Grillo F, Gervaso L, Arpa G, Fazio N, Vanoli A, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335117
The oncogene , also known as or , is located on chromosome 17 (q12). It encodes a tyrosine kinase receptor, the human epidermal growth factor receptor 2 (HER2), involved in...
2.
Vanoli A, Grillo F, De Lisi G, Guerini C, Arpa G, Klersy C, et al.
Histopathology
. 2024 Aug;
86(2):236-246.
PMID: 39192803
Aim: Gastrointestinal medullary carcinoma is a rare histologic subtype of adenocarcinoma. As nonampullary small bowel medullary carcinomas (SB-MCs) are poorly characterized, we aimed to analyse their clinicopathologic and immunohistochemical features...
3.
Mollica L, Quaquarini E, Schiepatti A, Travaglino E, Antoci F, Vanoli A, et al.
Clin J Gastroenterol
. 2024 Aug;
17(6):1026-1032.
PMID: 39117782
We present the case of a 62-year-old man with a history of celiac disease and IgA deficiency, following a strict gluten-free diet that was admitted to our hospital for recurrent...
4.
Palumbo R, Quaquarini E, Saltalamacchia G, Malovini A, Lapidari P, Tagliaferri B, et al.
Drugs Context
. 2024 Feb;
13.
PMID: 38332945
Background: Breast cancer is the most frequent tumour worldwide, and the HR/HER2 subtype is the most common. For this tumour type, endocrine therapy (ET) is the mainstay of treatment. The...
5.
Tagliaferri B, Mollica L, Palumbo R, Leli C, Malovini A, Terzaghi M, et al.
Drugs Context
. 2023 Jun;
12.
PMID: 37378079
Background: Advanced breast cancer (ABC) is characterized by multidimensional clinical complexity that is usually not considered in randomized clinical trials. In the present real-life study, we investigated the link between...
6.
Vanoli A, Guerini C, Arpa G, Klersy C, Grillo F, Casadei Gardini A, et al.
Dig Liver Dis
. 2023 May;
55(9):1261-1269.
PMID: 37236851
Background: Small bowel adenocarcinoma (SBA) is a rare cancer with an aggressive behavior. No study has specifically addressed the putative prognostic role of mismatch repair status in stage III SBAs....
7.
Saltalamacchia G, Bernardo A, Quaquarini E
Cancer Control
. 2023 Apr;
30:10732748231161466.
PMID: 37073789
Neoadjuvant chemotherapy was originally designed to convert inoperable cancer. Nowadays, this concept has expanded since it can also offer the possibility to evaluate markers of response such as pathological complete...
8.
Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, et al.
Drugs Context
. 2022 Sep;
11.
PMID: 36118250
Tumour markers have no established role in the monitoring of the course of metastatic breast cancer during antineoplastic therapy, yet cancer antigen 15.3 (CA15.3) and carcinoembryonic antigen (CEA) are commonly...
9.
Arpa G, Fassan M, Guerini C, Quaquarini E, Grillo F, Angerilli V, et al.
Virchows Arch
. 2022 Aug;
481(6):853-863.
PMID: 35925388
Non-ampullary small bowel adenocarcinoma is a rare neoplasm with an ominous prognosis, whose incidence is higher in some chronic immuno-inflammatory conditions, such as coeliac and Crohn's disease. Recently, claudin 18.2,...
10.
Quaquarini E, Sottotetti F, Agustoni F, Pozzi E, Malovini A, Teragni C, et al.
J Pers Med
. 2022 May;
12(5).
PMID: 35629102
Introduction: Immune checkpoint inhibitors (ICIs) have become the standard of treatment for patients with non-small cell lung cancer (NSCLC). However, there are still many uncertainties regarding the selection of the...